Aetion
Amr Kronfol is a Managing Director at Warburg Pincus since July 2009, specializing in growth investments that intersect healthcare, technology, and consumer/retail sectors. In addition to the role at Warburg Pincus, Amr serves as a Board Observer at Aetion and Helix, and as a Board Member for several companies including Qualifacts, WebPT, Modernizing Medicine, and Specialists On Call, Inc. Amr held a Board Member position at CITYMD from June 2017 to August 2019, and a Board Observer position at MercuryGate International from July 2014 to August 2018. Amr's educational background includes an MBA from The Wharton School (2007-2009) and a Bachelor of Arts in Computer Science from Princeton University (1998-2002).
This person is not in the org chart
This person is not in any teams
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.